Approval · Notice of Compliance 3973 · 1997
MIREZE: Notice of Compliance 3973
Issued January 30, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3973
- Date
- January 30, 1997
- Company
- Allergan IncMarkham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antiallergic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MIREZE | 02230446 | Cancelled Post Market |
Medicinal ingredients
- NEDOCROMIL SODIUM 2 PER